REFERENCES
1. Noubiap JJ, Nyaga UF, Ndoadoumgue AL, Nkeck JR, Ngouo A, Bigna JJ. Meta-analysis of the incidence, prevalence, and correlates of atrial fibrillation in rheumatic heart disease. Glob Heart 2020;15:38.
2. Grigioni F, Benfari G, Vanoverschelde JL, et al. MIDA Investigators. Long-term implications of atrial fibrillation in patients with degenerative mitral regurgitation. J Am Coll Cardiol 2019;73:264-74.
3. Eguchi K, Ohtaki E, Matsumura T, et al. Pre-operative atrial fibrillation as the key determinant of outcome of mitral valve repair for degenerative mitral regurgitation. Eur Heart J 2005;26:1866-72.
4. Alexiou C, Doukas G, Oc M, et al. The effect of preoperative atrial fibrillation on survival following mitral valve repair for degenerative mitral regurgitation. Eur J Cardiothorac Surg 2007;31:586-91.
5. Mehta CK, McCarthy PM, Andrei AC, et al. De novo atrial fibrillation after mitral valve surgery. J Thorac Cardiovasc Surg 2018;156:1515-25.e11.
6. Bramer S, van Straten AH, Soliman Hamad MA, van den Broek KC, Maessen JG, Berreklouw E. New-onset postoperative atrial fibrillation predicts late mortality after mitral valve surgery. Ann Thorac Surg 2011;92:2091-6.
7. Kernis SJ, Nkomo VT, Messika-Zeitoun D, et al. Atrial fibrillation after surgical correction of mitral regurgitation in sinus rhythm: incidence, outcome, and determinants. Circulation 2004;110:2320-5.
8. Shen J, Lall S, Zheng V, Buckley P, Damiano RJ Jr, Schuessler RB. The persistent problem of new-onset postoperative atrial fibrillation: a single-institution experience over two decades. J Thorac Cardiovasc Surg 2011;141:559-70.
9. Bowdish ME, D’Agostino RS, Thourani VH, et al. The Society of Thoracic Surgeons Adult Cardiac Surgery Database: 2020 Update on Outcomes and Research. Ann Thorac Surg 2020;109:1646-55.
10. Malavasi VL, Fantecchi E, Tordoni V, et al. Atrial fibrillation pattern and factors affecting the progression to permanent atrial fibrillation. Intern Emerg Med 2021;16:1131-40.
11. Boilève V, Dreyfus J, Attias D, et al. Predictors of mitral annulus enlargement? Int J Cardiol 2018;270:349-52.
12. Keren G, Etzion T, Sherez J, et al. Atrial fibrillation and atrial enlargement in patients with mitral stenosis. Am Heart J 1987;114:1146-55.
15. Diker E, Aydogdu S, Özdemir M, et al. Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol 1996;77:96-8.
16. Negi PC, Sondhi S, Rana V, et al. Prevalence, risk determinants and consequences of atrial fibrillation in rheumatic heart disease: 6 years hospital based-Himachal Pradesh- Rheumatic Fever/Rheumatic Heart Disease (HP-RF/RHD) Registry. Indian Heart J 2018;70 Suppl 3:S68-73.
17. Bando K, Kasegawa H, Okada Y, et al. Impact of preoperative and postoperative atrial fibrillation on outcome after mitral valvuloplasty for nonischemic mitral regurgitation. J Thorac Cardiovasc Surg 2005;129:1032-40.
18. Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol 2011;58:1474-81.
19. Borger MA, Mansour MC, Levine RA. Atrial fibrillation and mitral valve prolapse: time to intervene? J Am Coll Cardiol 2019;73:275-7.
20. Gertz ZM, Raina A, Mountantonakis SE, et al. The impact of mitral regurgitation on patients undergoing catheter ablation of atrial fibrillation. Europace 2011;13:1127-32.
21. Lombard FW, Liang Y. Risk factors for mitral valve surgery: atrial fibrillation and pulmonary hypertension. Semin Cardiothorac Vasc Anesth 2019;23:57-69.
22. Zarse M, Deharo JC, Mast F, Allessie MA. Importance of right and left atrial dilation and linear ablation for perpetuation of sustained atrial fibrillation. J Cardiovasc Electrophysiol 2002;13:164-71.
23. Fan K, Lee KL, Chow WH, Chau E, Lau CP. Internal cardioversion of chronic atrial fibrillation during percutaneous mitral commissurotomy: insight into reversal of chronic stretch-induced atrial remodeling. Circulation 2002;105:2746-52.
24. Henry WL, Morganroth J, Pearlman AS, et al. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976;53:273-9.
25. Parkash R, Green MS, Kerr CR, et al. Canadian Registry of Atrial Fibrillation. The association of left atrial size and occurrence of atrial fibrillation: a prospective cohort study from the Canadian Registry of Atrial Fibrillation. Am Heart J 2004;148:649-54.
26. Zacà V, Galderisi M, Mondillo S, Focardi M, Ballo P, Guerrini F. Left atrial enlargement as a predictor of recurrences in lone paroxysmal atrial fibrillation. Can J Cardiol 2007;23:869-72.
27. John B, Stiles MK, Kuklik P, et al. Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J 2008;29:2234-43.
28. Lau DH, Linz D, Sanders P. New findings in atrial fibrillation mechanisms. Card Electrophysiol Clin 2019;11:563-71.
29. Iung B, Leenhardt A, Extramiana F. Management of atrial fibrillation in patients with rheumatic mitral stenosis. Heart 2018;104:1062-8.
30. Candan O, Gecmen C, Kalayci A, Dogan C, Bayam E, Ozkan M. Left atrial electromechanical conduction time predicts atrial fibrillation in patients with mitral stenosis: a 5-year follow-up speckle-tracking echocardiography study. Int J Cardiovasc Imaging 2017;33:1491-501.
31. John B, Lau CP. Atrial fibrillation in valvular heart disease. Card Electrophysiol Clin 2021;13:113-22.
32. Harada A, Sasaki K, Fukushima T, et al. Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg 1996;61:104-12.
33. Gammie JS, Chikwe J, Badhwar V, et al. Isolated mitral valve surgery: the society of thoracic surgeons adult cardiac surgery database analysis. Ann Thorac Surg 2018;106:716-27.
34. McCarthy PM, Davidson CJ, Kruse J, et al. Prevalence of atrial fibrillation before cardiac surgery and factors associated with concomitant ablation. J Thorac Cardiovasc Surg 2020;159:2245-53.e15.
35. Kim JY, Kim SH, Myong JP, et al. Ten-year trends in the incidence, treatment and outcomes of patients with mitral stenosis in Korea. Heart 2020;106:746-50.
36. Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2021;143:e35-71.
37. January CT, Wann LS, Alpert JS, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2014;64:e1-76.
38. Jame S, Barnes G. Stroke and thromboembolism prevention in atrial fibrillation. Heart 2020;106:10-7.
39. Hindricks G, Potpara T, Dagres N, et al. ESC Scientific Document Group. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 2021;42:373-498.
40. Beller JP, Krebs ED, Hawkins RB, et al. Non-vitamin K oral anticoagulant use after cardiac surgery is rapidly increasing. J Thorac Cardiovasc Surg 2020;160:1222-31.
41. Nathan AS, Yang L, Geng Z, et al. Oral anticoagulant use in patients with atrial fibrillation and mitral valve repair. Am Heart J 2021;232:1-9.
42. Malik AH, Yandrapalli S, Aronow WS, Panza JA, Cooper HA. Oral anticoagulants in atrial fibrillation with valvular heart disease and bioprosthetic heart valves. Heart 2019;105:1432-6.
43. Pan KL, Singer DE, Ovbiagele B, Wu YL, Ahmed MA, Lee M. Effects of non-vitamin K antagonist oral anticoagulants versus warfarin in patients with atrial fibrillation and valvular heart disease: a systematic review and meta-analysis. J Am Heart Assoc 2017;6:e005835.
44. de Souza Lima Bitar Y, Neto MG, Filho JAL, et al. Comparison of the new oral anticoagulants and warfarin in patients with atrial fibrillation and valvular heart disease: systematic review and meta-analysis. Drugs R D 2019;19:117-26.
45. Vinereanu D, Wang A, Mulder H, et al. Outcomes in anticoagulated patients with atrial fibrillation and with mitral or aortic valve disease. Heart 2018;104:1292-9.
46. Darby AE, Dimarco JP. Management of atrial fibrillation in patients with structural heart disease. Circulation 2012;125:945-57.
47. Gillinov AM, Bagiella E, Moskowitz AJ, et al. CTSN. Rate control versus rhythm control for atrial fibrillation after cardiac surgery. N Engl J Med 2016;374:1911-21.
48. Sethi NJ, Feinberg J, Nielsen EE, Safi S, Gluud C, Jakobsen JC. The effects of rhythm control strategies versus rate control strategies for atrial fibrillation and atrial flutter: a systematic review with meta-analysis and Trial Sequential Analysis. PLoS One 2017;12:e0186856.
49. Alzahrani T, McCaffrey J, Mercader M, Solomon A. Rate versus rhythm control in patients with normal to mild left atrial enlargement: insights from the AFFIRM trial. J Atr Fibrillation 2018;11:2067.
50. Carlsson J, Miketic S, Windeler J, et al. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation. J Am Coll Cardiol 2003;41:1690-6.
51. Wyse DG, Waldo AL, DiMarco JP. Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-33.
52. Van Gelder IC, Hagens VE, Bosker HA, et al. Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002;347:1834-40.
53. Badhwar V, Rankin JS, Damiano RJ Jr, et al. The Society of Thoracic Surgeons 2017 Clinical Practice Guidelines for the Surgical Treatment of Atrial Fibrillation. Ann Thorac Surg 2017;103:329-41.
54. Gangani K, Alkhaimy H, Patil N, et al. Impact of paroxysmal versus non-paroxysmal atrial fibrillation on outcomes in patients undergoing transcatheter mitral valve repair. Cardiovasc Diagn Ther 2020;10:31-5.
55. Bando K, Kobayashi J, Kosakai Y, et al. Impact of Cox maze procedure on outcome in patients with atrial fibrillation and mitral valve disease. J Thorac Cardiovasc Surg 2002;124:575-83.
56. Anselmino M, Rovera C, Marchetto G, et al. Left atrial function after atrial fibrillation cryoablation concomitant to minimally invasive mitral valve repair: a pilot study on long-term results and clinical implications. Medicina (Kaunas) 2019;55:709.
57. Labin JE, Haque N, Sinn LA, et al. The Cox-Maze IV procedure for atrial fibrillation is equally efficacious in patients with rheumatic and degenerative mitral valve disease. J Thorac Cardiovasc Surg 2017;154:835-44.
58. Kim WK, Kim HJ, Kim JB, et al. Concomitant ablation of atrial fibrillation in rheumatic mitral valve surgery. J Thorac Cardiovasc Surg 2019;157:1519-28.e5.
59. Gillinov AM, Gelijns AC, Parides MK, et al. CTSN Investigators. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med 2015;372:1399-409.
60. Chavez EK, Colafranceschi AS, Monteiro AJO, et al. Surgical treatment of atrial fibrillation in patients with rheumatic valve disease. Braz J Cardiovasc Surg 2017;32:202-9.
61. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary. Europace 2018;20:157-208.
62. Alturki A, Huynh T, Dawas A, Essebag V. The impact of empirical left atrial appendage isolation in atrial fibrillation catheter ablation: a meta-analysis. Can J Cardiol 2017;33:S151.
63. Yorgun H, Canpolat U, Okşul M, et al. Long-term outcomes of cryoballoon-based left atrial appendage isolation in addition to pulmonary vein isolation in persistent atrial fibrillation. Europace 2019;21:1653-62.
64. McClure GR, Belley-Cote EP, Jaffer IH, et al. Surgical ablation of atrial fibrillation: a systematic review and meta-analysis of randomized controlled trials. Europace 2018;20:1442-50.
65. Willy K, Reinke F, Ellermann C, et al. Long-term experience of atrioventricular node ablation in patients with refractory atrial arrhythmias. Heart Vessels 2020;35:699-704.
66. Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry NK, Singh JP. Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circ Arrhythm Electrophysiol 2012;5:68-76.
67. Vlachos K, Letsas KP, Korantzopoulos P, Liu T, Efremidis M, Sideris A. A review on atrioventricular junction ablation and pacing for heart rate control of atrial fibrillation. J Geriatr Cardiol 2015;12:547-54.
68. Tan ES, Rienstra M, Wiesfeld AC, Schoonderwoerd BA, Hobbel HH, Van Gelder IC. Long-term outcome of the atrioventricular node ablation and pacemaker implantation for symptomatic refractory atrial fibrillation. Europace 2008;10:412-8.
69. Aliot E, De Chillou C, Sadoul N. Catheter ablation or modulation of the AV node. Card Electrophysiol Rev 2002;6:406-13.
70. Garcia B, Clementy N, Benhenda N, et al. Mortality after atrioventricular nodal radiofrequency catheter ablation with permanent ventricular pacing in atrial fibrillation: outcomes from a controlled nonrandomized study. Circ Arrhythm Electrophysiol 2016;9:e003993.
71. Centurión OA, Scavenius KE, García LB, Miño L, Torales J, Sequeira O. Atrioventricular nodal catheter ablation in atrial fibrillation complicating congestive heart failure. J Atr Fibrillation 2018;11:1813.
72. Wang B, Xu ZY, Han L, Zhang GX, Lu FL, Song ZG. Impact of preoperative atrial fibrillation on mortality and cardiovascular outcomes of mechanical mitral valve replacement for rheumatic mitral valve disease. Eur J Cardiothorac Surg 2013;43:513-9.
73. Coutinho GF, Garcia AL, Correia PM, Branco C, Antunes MJ. Negative impact of atrial fibrillation and pulmonary hypertension after mitral valve surgery in asymptomatic patients with severe mitral regurgitation: a 20-year follow-up. Eur J Cardiothorac Surg 2015;48:548-55; discussion 555-6.
74. Ngaage DL, Schaff HV, Mullany CJ, et al. Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 2007;84:434-42; discussion 442-3.
75. DeRose JJ Jr, Mancini DM, Chang HL, et al. CTSN Investigators. Pacemaker implantation after mitral valve surgery with atrial fibrillation ablation. J Am Coll Cardiol 2019;73:2427-35.
76. Murashita T, Okada Y, Kanemitsu H, et al. Long-term outcomes after mitral valve repair for degenerative mitral regurgitation with persistent atrial fibrillation. Thorac Cardiovasc Surg 2015;63:243-9.
77. Ad N, Holmes SD, Massimiano PS, Rongione AJ, Fornaresio LM. Long-term outcome following concomitant mitral valve surgery and Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg 2018;155:983-94.
78. Ad N, Holmes SD, Ali R, Pritchard G, Lamont D. A single center’s experience with pacemaker implantation after the Cox maze procedure for atrial fibrillation. J Thorac Cardiovasc Surg 2017;154:139-146.e1.
80. Wang H, Han J, Wang Z, et al. Efficacy of cut-and-sew surgical ablation for atrial fibrillation in patients with giant left atria undergoing mitral valve surgery: a propensity-matched analysis. Semin Thorac Cardiovasc Surg 2019;31:796-802.
81. Jiang S, Zhang H, Wei S, et al. Left atrial appendage exclusion is effective in reducing postoperative stroke after mitral valve replacement. J Card Surg 2020;35:3395-402.
82. Kim WK, Kim HJ, Kim JB, et al. Exclusion versus preservation of the left atrial appendage in rheumatic mitral valve surgery. Heart 2020;106:1839-46.
83. Lavalle C, Straito M, Chourda E, et al. Left atrial appendage exclusion in atrial fibrillation radiofrequency ablation during mitral valve surgery: a single-center experience. Cardiol Res Pract 2021;2021:9999412.
84. Abrich VA, Narichania AD, Love WT, Lanza LA, Shen WK, Sorajja D. Left atrial appendage exclusion during mitral valve surgery and stroke in atrial fibrillation. J Interv Card Electrophysiol 2018;53:285-92.
85. Subahi A, Munir A, Abubakar H, et al. The impact of atrial fibrillation on transcatheter mitral valve repair outcomes: a propensity-matched analysis. J Interv Cardiol 2018;31:925-31.
86. Kaur S, Sadana D, Patel J, et al. Atrial fibrillation and transcatheter repair of functional mitral regurgitation: evidence from a meta-regression. JACC Cardiovasc Interv 2020;13:2374-84.
87. Arora S, Vemulapalli S, Stebbins A, et al. The prevalence and impact of atrial fibrillation on 1-year outcomes in patients undergoing transcatheter mitral valve repair: results from the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. JACC Cardiovasc Interv 2019;12:569-78.
88. Sun F, Liu H, Zhang Q, Lu F, Zhan H, Zhou J. Impact of atrial fibrillation on outcomes of patients treated by transcatheter mitral valve repair: a systematic review and meta-analysis. Medicine (Baltimore) 2020;99:e22195.
89. Saad AM, Kassis N, Gad MM, et al. Impact of atrial fibrillation on outcomes following MitraClip: a contemporary population-based analysis. Catheter Cardiovasc Interv 2021;97:1252-6.
90. Shah S, Raj V, Abdelghany M, et al. Impact of atrial fibrillation on the outcomes of transcatheter mitral valve repair using MitraClip: a systematic review and meta-analysis. Heart Fail Rev 2021;26:531-43.
91. Keßler M, Pott A, Mammadova E, et al. Atrial fibrillation predicts long-term outcome after transcatheter edge-to-edge mitral valve repair by MitraClip implantation. Biomolecules 2018;8:152.
92. Velu JF, Kortlandt FA, Hendriks T, et al. Comparison of outcome after percutaneous mitral valve repair with the MitraClip in patients with versus without atrial fibrillation. Am J Cardiol 2017;120:2035-40.
93. Gertz ZM, Herrmann HC, Lim DS, et al. Implications of atrial fibrillation on the mechanisms of mitral regurgitation and response to MitraClip in the COAPT trial. Circ Cardiovasc Interv 2021;14:e010300.
94. Healey JS, Amit G, Field TS. Atrial fibrillation and stroke: how much atrial fibrillation is enough to cause a stroke? Curr Opin Neurol 2020;33:17-23.
95. Nishino S, Watanabe N, Ashikaga K, et al. Reverse remodeling of the mitral valve complex after radiofrequency catheter ablation for atrial fibrillation: a serial 3-dimensional echocardiographic study. Circ Cardiovasc Imaging 2019;12:e009317.
96. Wu JT, Zaman JAB, Yakupoglu HY, et al. Catheter ablation of atrial fibrillation in patients with functional mitral regurgitation and left ventricular systolic dysfunction. Front Cardiovasc Med 2020;7:596491.
97. Weerasooriya R, Khairy P, Litalien J, et al. Catheter ablation for atrial fibrillation: are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011;57:160-6.
98. Gaita F, Scaglione M, Battaglia A, et al. Very long-term outcome following transcatheter ablation of atrial fibrillation. Are results maintained after 10 years of follow up? Europace 2018;20:443-50.
99. Chen J, Wang H, Zhao L. Long-term outcomes of radiofrequency catheter ablation for atrial fibrillation in rheumatic heart disease patients with mild mitral stenosis. J Interv Card Electrophysiol 2019;56:313-9.
100. von Oppell UO, Masani N, O’Callaghan P, Wheeler R, Dimitrakakis G, Schiffelers S. Mitral valve surgery plus concomitant atrial fibrillation ablation is superior to mitral valve surgery alone with an intensive rhythm control strategy. Eur J Cardiothorac Surg 2009;35:641-50.
101. Phan K, Xie A, Tian DH, Shaikhrezai K, Yan TD. Systematic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery. Ann Cardiothorac Surg 2014;3:3-14.
102. Liu X, Tan HW, Wang XH, et al. Efficacy of catheter ablation and surgical CryoMaze procedure in patients with long-lasting persistent atrial fibrillation and rheumatic heart disease: a randomized trial. Eur Heart J 2010;31:2633-41.
103. Chen J, Xie X, Zhang J, et al. Catheter ablation versus surgical ablation combined with mitral valve surgery for nonparoxysmal atrial fibrillation in patients with moderate mitral regurgitation. J Cardiovasc Electrophysiol 2019;30:332-8.
104. Gialdini G, Nearing K, Bhave PD, et al. Perioperative atrial fibrillation and the long-term risk of ischemic stroke. JAMA 2014;312:616-22.
105. Lin MH, Kamel H, Singer DE, Wu YL, Lee M, Ovbiagele B. Perioperative/postoperative atrial fibrillation and risk of subsequent stroke and/or mortality. Stroke 2019;50:1364-71.
106. Joshi KK, Tiru M, Chin T, Fox MT, Stefan MS. Postoperative atrial fibrillation in patients undergoing non-cardiac non-thoracic surgery: a practical approach for the hospitalist. Hosp Pract (1995) 2015;43:235-44.
107. Frendl G, Sodickson AC, Chung MK, et al. American Association for Thoracic Surgery. 2014 AATS guidelines for the prevention and management of perioperative atrial fibrillation and flutter for thoracic surgical procedures. J Thorac Cardiovasc Surg 2014;148:e153-93.
108. Asher CR, Miller DP, Grimm RA, Cosgrove DM, Chung MK. Analysis of risk factors for development of atrial fibrillation early after cardiac valvular surgery. Am J Cardiol 1998;82:892-5.
109. Mirhosseini SJ, Ali-Hassan-Sayegh S, Hadadzadeh M, Naderi N, Mostafavi Pour Manshadi SM. Atrial fibrillation and early clinical outcomes after mitral valve surgery in patients with rheumatic vs. non-rheumatic mitral stenosis. Heart Views 2012;13:136-8.
110. Balachandran P, Schaff HV, Lahr BD, et al. Preoperative left atrial volume index is associated with postoperative outcomes in mitral valve repair for chronic mitral regurgitation. J Thorac Cardiovasc Surg 2020;160:661-72.e5.
111. Kawamoto N, Fujita T, Fukushima S, et al. Late onset of atrial fibrillation in patients undergoing mitral valve repair for type II dysfunction. J Cardiol 2018;71:346-51.
112. Kang MK, Joung B, Shim CY, et al. Post-operative left atrial volume index is a predictor of the occurrence of permanent atrial fibrillation after mitral valve surgery in patients who undergo mitral valve surgery. Cardiovasc Ultrasound 2018;16:5.
113. Jin Y, Wang Y, Zhang J, et al. Left atrial mechanical function predicts postoperative AF in patients with rheumatic mitral valve disease who underwent mitral valve surgery. Heart Surg Forum 2020;23:E907-12.
114. Bo H, Heinzmann D, Grasshoff C, et al. ECG changes after percutaneous edge-to-edge mitral valve repair. Clin Cardiol 2019;42:1094-9.
115. Soylu M, Demir AD, Ozdemir O, et al. Evaluation of atrial refractoriness immediately after percutaneous mitral balloon commissurotomy in patients with mitral stenosis and sinus rhythm. Am Heart J 2004;147:741-5.
116. Sigurdsson MI, Saddic L, Heydarpour M, et al. Post-operative atrial fibrillation examined using whole-genome RNA sequencing in human left atrial tissue. BMC Med Genomics 2017;10:25.
117. Echahidi N, Pibarot P, O'Hara G, Mathieu P. Mechanisms, prevention, and treatment of atrial fibrillation after cardiac surgery. J Am Coll Cardiol 2008;51:793-801.
118. Ma W, Shi W, Wu W, et al. Elevated gradient after mitral valve repair: the effect of surgical technique and relevance of postoperative atrial fibrillation. J Thorac Cardiovasc Surg 2019;157:921-7.e3.
119. Beukema RJ, Adiyaman A, Smit JJ, Delnoy PP, Ramdat Misier AR, Elvan A. Catheter ablation of symptomatic postoperative atrial arrhythmias after epicardial surgical disconnection of the pulmonary veins and left atrial appendage ligation in patients with atrial fibrillation. Eur J Cardiothorac Surg 2016;49:265-71.
120. Bessissow A, Khan J, Devereaux PJ, Alvarez-Garcia J, Alonso-Coello P. Postoperative atrial fibrillation in non-cardiac and cardiac surgery: an overview. J Thromb Haemost 2015;13 Suppl 1:S304-12.
121. Maesen B, Nijs J, Maessen J, Allessie M, Schotten U. Post-operative atrial fibrillation: a maze of mechanisms. Europace 2012;14:159-74.
122. Di Prima AL, Covello DR, Franco A, et al. Do patients undergoing MitraClip implantation require routine ICU admission? J Cardiothorac Vasc Anesth 2014;28:1479-83.
123. Sharma S, Angral R, Saini H. Effect of prophylaxis of amiodarone and magnesium to prevent atrial fibrillation in patients with rheumatic valve disease undergoing mitral valve replacement surgery. Anesth Essays Res 2020;14:189-93.
124. Kar SK, Dasgupta CS, Goswami A. Effect of prophylactic amiodarone in patients with rheumatic valve disease undergoing valve replacement surgery. Ann Card Anaesth 2011;14:176-82.
125. Cappabianca G, Rotunno C, de Luca Tupputi Schinosa L, Ranieri VM, Paparella D. Protective effects of steroids in cardiac surgery: a meta-analysis of randomized double-blind trials. J Cardiothorac Vasc Anesth 2011;25:156-65.
126. Lee JZ, Singh N, Howe CL, et al. Colchicine for prevention of post-operative atrial fibrillation: a meta-analysis. JACC Clin Electrophysiol 2016;2:78-85.
127. Ronsoni RM, Souza AZM, Leiria TLL, Lima GG. Update on management of postoperative atrial fibrillation after cardiac surgery. Braz J Cardiovasc Surg 2020;35:206-10.
128. Hui DS, Lee R. Treatment of postoperative atrial fibrillation: the long road ahead. J Thorac Cardiovasc Surg 2020;159:1840-3.
129. Corcia MC, Walsh EP, Emani S. Long-term results of atrial maze surgery in patients with congenital heart disease. Europace 2019;21:1345-52.
130. Marazzato J, Cappabianca G, Angeli F, et al. Catheter ablation of atrial tachycardias after mitral valve surgery: a systematic review and meta-analysis. J Cardiovasc Electrophysiol 2020;31:2632-41.
131. Mamchur SE, Mamchur IN, Khomenko EA, Gorbunova EV, Sizova IN, Odarenko YN. Catheter ablation for atrial fibrillation after an unsuccessful surgical ablation and biological prosthetic mitral valve replacement: a pilot study. J Chin Med Assoc 2014;77:409-15.
132. Doshi R, Patel K, Desai R, Patel K, Gupta R. Incidence and impact of new-onset atrial fibrillation on transcatheter mitral valve repair. Eur J Intern Med 2019;60:e18-9.
133. Rottner L, Lemes C, Dotz I, et al. The clip and the tip: lessons learned from ablation of atrial fibrillation in patients postpercutaneous mitral valve repair. J Cardiovasc Electrophysiol 2019;30:1207-14.
134. Hussein AA, Wazni OM, Harb S, et al. Radiofrequency ablation of atrial fibrillation in patients with mechanical mitral valve prostheses safety, feasibility, electrophysiologic findings, and outcomes. J Am Coll Cardiol 2011;58:596-602.
135. Ahlsson A, Fengsrud E, Bodin L, Englund A. Postoperative atrial fibrillation in patients undergoing aortocoronary bypass surgery carries an eightfold risk of future atrial fibrillation and a doubled cardiovascular mortality. Eur J Cardiothorac Surg 2010;37:1353-9.
136. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol 2019;74:104-32.
137. Mehaffey JH, Krebs E, Hawkins RB, et al. Variability and utilization of concomitant atrial fibrillation ablation during mitral valve surgery. Ann Thorac Surg 2021;111:29-34.
138. Ando M, Funamoto M, Cameron DE, Sundt TM 3rd. Concomitant surgical closure of left atrial appendage: a systematic review and meta-analysis. J Thorac Cardiovasc Surg 2018;156:1071-80.e2.
139. Xie X, Liu X, Chen B, Wang Q. Prophylactic atrial fibrillation ablation in atrial flutter patients without atrial fibrillation: a meta-analysis with trial sequential analysis. Med Sci Monit Basic Res 2018;24:96-102.
140. Schueler R, Nickenig G, May AE, et al. Predictors for short-term outcomes of patients undergoing transcatheter mitral valve interventions: analysis of 778 prospective patients from the German TRAMI registry focusing on baseline renal function. EuroIntervention 2016;12:508-14.
141. Chua YL, Schaff HV, Orszulak TA, Morris JJ. Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty? J Thorac Cardiovasc Surg 1994;107:408-15.
142. Leon MN, Harrell LC, Simosa HF, et al. Mitral balloon valvotomy for patients with mitral stenosis in atrial fibrillation: immediate and long-term results. J Am Coll Cardiol 1999;34:1145-52.
143. Tribouilloy CM, Enriquez-Sarano M, Schaff HV, et al. Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 1999;99:400-5.
144. Jessurun ER, van Hemel NM, Kelder JC, et al. Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed? Eur J Cardiothorac Surg 2000;17:530-7.
145. Lim E, Barlow CW, Hosseinpour AR, et al. Influence of atrial fibrillation on outcome following mitral valve repair. Circulation 2001;104:I59-63.
146. Bando K, Kobayashi J, Hirata M, et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg 2003;126:358-63.
147. Itoh A, Kobayashi J, Bando K, et al. The impact of mitral valve surgery combined with maze procedure. Eur J Cardiothorac Surg 2006;29:1030-5.
148. Funatsu T, Kobayashi J, Nakajima H, Iba Y, Shimahara Y, Yagihara T. Long-term results and reliability of cryothermic ablation based maze procedure for atrial fibrillation concomitant with mitral valve surgery. Eur J Cardiothorac Surg 2009;36:267-71; discussion 271.
149. Fujita T, Kobayashi J, Toda K, et al. Long-term outcome of combined valve repair and maze procedure for nonrheumatic mitral regurgitation. J Thorac Cardiovasc Surg 2010;140:1332-7.
150. Saint LL, Damiano RJ Jr, Cuculich PS, et al. Incremental risk of the Cox-maze IV procedure for patients with atrial fibrillation undergoing mitral valve surgery. J Thorac Cardiovasc Surg 2013;146:1072-7.
151. Yoo JS, Kim JB, Jung SH, Choo SJ, Chung CH, Lee JW. Impact of the maze procedure and postoperative atrial fibrillation on progression of functional tricuspid regurgitation in patients undergoing degenerative mitral repair. Eur J Cardiothorac Surg 2013;43:520-5.
152. Tomai F, Gaspardone A, Versaci F, et al. Twenty year follow-up after successful percutaneous balloon mitral valvuloplasty in a large contemporary series of patients with mitral stenosis. Int J Cardiol 2014;177:881-5.
153. Nickenig G, Estevez-Loureiro R, Franzen O, et al. Transcatheter Valve Treatment Sentinel Registry Investigators of the EURObservational Research Programme of the European Society of Cardiology. Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. J Am Coll Cardiol 2014;64:875-84.
154. Capodanno D, Adamo M, Barbanti M, et al. GRASP-IT Investigators. Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair. Am Heart J 2015;170:187-95.
155. Giannini C, Fiorelli F, Colombo A, et al. Right ventricular evaluation to improve survival outcome in patients with severe functional mitral regurgitation and advanced heart failure undergoing MitraClip therapy. Int J Cardiol 2016;223:574-80.
156. Puls M, Lubos E, Boekstegers P, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry. Eur Heart J 2016;37:703-12.
157. Jabs A, von Bardeleben RS, Boekstegers P, et al. Effects of atrial fibrillation and heart rate on percutaneous mitral valve repair with MitraClip: results from the TRAnscatheter Mitral valve Interventions (TRAMI) registry. EuroIntervention 2017;12:1697-705.
158. Sorajja P, Vemulapalli S, Feldman T, et al. Outcomes with transcatheter mitral valve repair in the United States: an STS/ACC TVT registry report. J Am Coll Cardiol 2017;70:2315-27.
159. Spieker M, Hellhammer K, Spießhöfer J, et al. Effect of atrial fibrillation and mitral valve gradients on response to percutaneous mitral valve repair with the MitraClip system. Am J Cardiol 2018;122:1371-8.
160. Kim D, Chung H, Nam JH, et al. Predictors of long-term outcomes of percutaneous mitral valvuloplasty in patients with rheumatic mitral stenosis. Yonsei Med J 2018;59:273-8.
161. Kitamura M, Kaneko H, Schlüter M, et al. Predictors of mortality in ischaemic versus non-ischaemic functional mitral regurgitation after successful transcatheter mitral valve repair using MitraClip: results from two high-volume centres. Clin Res Cardiol 2019;108:264-72.
162. Ailawadi G, Lim DS, Mack MJ, et al. EVEREST II Investigators. One-year outcomes after MitraClip for functional mitral regurgitation. Circulation 2019;139:37-47.
